{"acquisitions":[],"changes":[{"companyHref":"/c/superluminalmedicines-com","date":"2026-09-28","documentUrl":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml","domain":"superluminalmedicines.com","fact":"latest round","name":"Superluminal Medicines, Inc.","new":{"amountUsd":65480796,"date":"2026-08-10","lead":null,"type":null},"old":{"amountUsd":5000000,"date":"2025-08-26","lead":null,"type":null},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-28","slug":"superluminalmedicines-com","status":"sourced","url":"https://whoraisedwhat.com/c/superluminalmedicines-com"},{"companyHref":"/c/superluminalmedicines-com","date":"2026-09-28","documentUrl":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml","domain":"superluminalmedicines.com","fact":"provenance:round","name":"Superluminal Medicines, Inc.","new":{"publisher":"SEC EDGAR","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"},"old":{"publisher":"SEC EDGAR","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-28","slug":"superluminalmedicines-com","status":"sourced","url":"https://whoraisedwhat.com/c/superluminalmedicines-com"},{"companyHref":"/c/superluminalmedicines-com","date":"2026-09-28","documentUrl":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml","domain":"superluminalmedicines.com","fact":"total raised","name":"Superluminal Medicines, Inc.","new":"116201563","old":"5000000","publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-28","slug":"superluminalmedicines-com","status":"sourced","url":"https://whoraisedwhat.com/c/superluminalmedicines-com"},{"companyHref":"/c/superluminalmedicines-com","date":"2026-09-25","documentUrl":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml","domain":"superluminalmedicines.com","fact":"latest round","name":"Superluminal Medicines, Inc.","new":{"amountUsd":5000000,"date":"2025-08-26","lead":null,"type":null},"old":{"amountUsd":5000000,"date":"2025-08-26","lead":null,"type":"seed"},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-25","slug":"superluminalmedicines-com","status":"sourced","url":"https://whoraisedwhat.com/c/superluminalmedicines-com"},{"companyHref":"/c/superluminalmedicines-com","date":"2026-09-25","documentUrl":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml","domain":"superluminalmedicines.com","fact":"provenance:round","name":"Superluminal Medicines, Inc.","new":{"publisher":"SEC EDGAR","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},"old":{"publisher":"sec-edgar","status":"attributed","url":null},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-25","slug":"superluminalmedicines-com","status":"sourced","url":"https://whoraisedwhat.com/c/superluminalmedicines-com"}],"country":"US","description":"Biotechnology company based in BOSTON, MA","domain":"superluminalmedicines.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":42.358834,"lng":-71.05783,"location":"BOSTON, MA","multiples":[],"name":"Superluminal Medicines, Inc.","people":[{"name":"ANDREW LEVIN","role":"director","slug":"andrew-levin"},{"name":"CATHERINE RIESEN","role":"executive","slug":"catherine-riesen"},{"name":"CONY D'CRUZ","role":"director","slug":"cony-d-cruz"},{"name":"CONY D'CRUZ","role":"executive","slug":"cony-d-cruz"},{"name":"CONY D'CRUZ","role":"promoter","slug":"cony-d-cruz"},{"name":"CRAIG RANDALL","role":"executive","slug":"craig-randall"},{"name":"DIAMANTIS XYLAS","role":"director","slug":"diamantis-xylas-2"},{"name":"DYLAN MORRIS","role":"director","slug":"dylan-morris"},{"name":"HARSHA PALADUGU","role":"director","slug":"harsha-paladugu"},{"name":"NANDITA SHANGARI","role":"director","slug":"nandita-shangari"}],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":65480796,"connectionsAmong":[{"a":"p/cony-d-cruz","b":"p/diamantis-xylas-2","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/diamantis-xylas-2","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2024-09-04","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/harsha-paladugu","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/harsha-paladugu","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2026-09-03","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/nandita-shangari","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/nandita-shangari","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2026-09-03","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/diamantis-xylas-2","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/diamantis-xylas-2","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2024-09-04","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/diamantis-xylas-2","b":"p/harsha-paladugu","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/diamantis-xylas-2","b":"p/harsha-paladugu","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2026-09-03","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/diamantis-xylas-2","b":"p/nandita-shangari","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/diamantis-xylas-2","b":"p/nandita-shangari","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2026-09-03","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/dylan-morris","b":"p/harsha-paladugu","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/dylan-morris","b":"p/harsha-paladugu","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2026-09-03","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/dylan-morris","b":"p/nandita-shangari","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/dylan-morris","b":"p/nandita-shangari","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2026-09-03","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/harsha-paladugu","b":"p/nandita-shangari","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/harsha-paladugu","b":"p/nandita-shangari","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2026-09-03","type":"worked_with","via":"c/superluminalmedicines-com"}],"currency":"USD","date":"2026-08-10","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"},"name":"CONY D'CRUZ","role":"director","roleAsStated":"Director","slug":"cony-d-cruz"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"},"name":"CONY D'CRUZ","role":"executive","roleAsStated":"Executive Officer","slug":"cony-d-cruz"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"},"name":"CONY D'CRUZ","role":"promoter","roleAsStated":"Promoter","slug":"cony-d-cruz"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"},"name":"DIAMANTIS XYLAS","role":"director","roleAsStated":"Director","slug":"diamantis-xylas-2"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"},"name":"DYLAN MORRIS","role":"director","roleAsStated":"Director","slug":"dylan-morris"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"},"name":"HARSHA PALADUGU","role":"director","roleAsStated":"Director","slug":"harsha-paladugu"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"},"name":"NANDITA SHANGARI","role":"director","roleAsStated":"Director","slug":"nandita-shangari"}],"slug":"superluminalmedicines-com-2026-08-10-round-0001989478-26-000001","source":{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-28","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"},"status":"sourced","type":null,"url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"},{"amountQuarantined":false,"amountUsd":5000000,"connectionsAmong":[{"a":"p/andrew-levin","b":"p/cony-d-cruz","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/andrew-levin","b":"p/cony-d-cruz","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/andrew-levin","b":"p/diamantis-xylas-2","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/andrew-levin","b":"p/diamantis-xylas-2","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"}],"since":"2024-09-04","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/andrew-levin","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/andrew-levin","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/diamantis-xylas-2","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/diamantis-xylas-2","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2024-09-04","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/diamantis-xylas-2","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/diamantis-xylas-2","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2024-09-04","type":"worked_with","via":"c/superluminalmedicines-com"}],"currency":"USD","date":"2025-08-26","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},"name":"ANDREW LEVIN","role":"director","roleAsStated":"Director","slug":"andrew-levin"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},"name":"CONY D'CRUZ","role":"director","roleAsStated":"Director","slug":"cony-d-cruz"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},"name":"CONY D'CRUZ","role":"executive","roleAsStated":"Executive Officer","slug":"cony-d-cruz"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},"name":"CONY D'CRUZ","role":"promoter","roleAsStated":"Promoter","slug":"cony-d-cruz"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},"name":"DIAMANTIS XYLAS","role":"director","roleAsStated":"Director","slug":"diamantis-xylas-2"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},"name":"DYLAN MORRIS","role":"director","roleAsStated":"Director","slug":"dylan-morris"}],"slug":"superluminalmedicines-com-2025-08-26-round","source":{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-25","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},"status":"sourced","type":null,"url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"amountQuarantined":false,"amountUsd":20041660,"connectionsAmong":[{"a":"p/andrew-levin","b":"p/catherine-riesen","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/andrew-levin","b":"p/cony-d-cruz","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/andrew-levin","b":"p/cony-d-cruz","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/andrew-levin","b":"p/diamantis-xylas-2","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/andrew-levin","b":"p/diamantis-xylas-2","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"}],"since":"2024-09-04","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/andrew-levin","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/andrew-levin","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/catherine-riesen","b":"p/cony-d-cruz","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/catherine-riesen","b":"p/diamantis-xylas-2","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"}],"since":"2024-09-04","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/catherine-riesen","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/diamantis-xylas-2","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/diamantis-xylas-2","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2024-09-04","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/diamantis-xylas-2","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/diamantis-xylas-2","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2024-09-04","type":"worked_with","via":"c/superluminalmedicines-com"}],"currency":"USD","date":"2024-08-21","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},"name":"ANDREW LEVIN","role":"director","roleAsStated":"Director","slug":"andrew-levin"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},"name":"CATHERINE RIESEN","role":"executive","roleAsStated":"Executive Officer","slug":"catherine-riesen"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},"name":"CONY D'CRUZ","role":"director","roleAsStated":"Director","slug":"cony-d-cruz"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},"name":"CONY D'CRUZ","role":"executive","roleAsStated":"Executive Officer","slug":"cony-d-cruz"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},"name":"CONY D'CRUZ","role":"promoter","roleAsStated":"Promoter","slug":"cony-d-cruz"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},"name":"DIAMANTIS XYLAS","role":"director","roleAsStated":"Director","slug":"diamantis-xylas-2"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},"name":"DYLAN MORRIS","role":"director","roleAsStated":"Director","slug":"dylan-morris"}],"slug":"superluminalmedicines-com-2024-08-21-round-0001989478-24-000001","source":{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-28","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},"status":"sourced","type":null,"url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"amountQuarantined":false,"amountUsd":25679107,"connectionsAmong":[{"a":"p/andrew-levin","b":"p/catherine-riesen","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/andrew-levin","b":"p/cony-d-cruz","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/andrew-levin","b":"p/cony-d-cruz","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/andrew-levin","b":"p/craig-randall","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/andrew-levin","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/andrew-levin","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/catherine-riesen","b":"p/cony-d-cruz","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/catherine-riesen","b":"p/craig-randall","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/catherine-riesen","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/craig-randall","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/superluminalmedicines-com"},{"a":"p/cony-d-cruz","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947824000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947825000001/primary_doc.xml"},{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"},{"a":"p/craig-randall","b":"p/dylan-morris","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"}],"since":"2023-08-28","type":"worked_with","via":"c/superluminalmedicines-com"}],"currency":"USD","date":"2023-03-03","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},"name":"ANDREW LEVIN","role":"director","roleAsStated":"Director","slug":"andrew-levin"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},"name":"CATHERINE RIESEN","role":"executive","roleAsStated":"Executive Officer","slug":"catherine-riesen"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},"name":"CONY D'CRUZ","role":"director","roleAsStated":"Director","slug":"cony-d-cruz"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},"name":"CONY D'CRUZ","role":"executive","roleAsStated":"Executive Officer","slug":"cony-d-cruz"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},"name":"CONY D'CRUZ","role":"promoter","roleAsStated":"Promoter","slug":"cony-d-cruz"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},"name":"CRAIG RANDALL","role":"executive","roleAsStated":"Executive Officer","slug":"craig-randall"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},"name":"DYLAN MORRIS","role":"director","roleAsStated":"Director","slug":"dylan-morris"}],"slug":"superluminalmedicines-com-2023-03-03-round-0001989478-23-000002","source":{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-28","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"},"status":"sourced","type":null,"url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947823000002/primary_doc.xml"}],"slug":"superluminalmedicines-com","sources":[{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-28","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1989478/000198947826000001/primary_doc.xml"},{"fact":"existence","publisher":"superluminalmedicines.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://superluminalmedicines.com"},{"fact":"description","publisher":"superluminalmedicines.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://superluminalmedicines.com"}],"stage":null,"stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":[],"totalRaisedUsd":116201563,"traction":[],"updatedAt":"2026-05-08","valuations":[]}